Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Discovering Urinary Protein Biomarkers for Hepatocellular Carcinoma in Chronic Hepatitis B Population
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Evaluation of Immune Responses and Outcomes in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy
- Status
- RECRUITING
- Phase
- N/A
Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）.
- Status
- RECRUITING
- Phase
- PHASE2
A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial for First-line Treatment of Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
HAIC Combined With Durvalumab and Tremelimumab and Lenvatinib in uHCC
- Status
- RECRUITING
- Phase
- PHASE2
Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Second-line Treatment With CAdonilimab and LEnvatinib for Unresectable HCC
- Status
- WITHDRAWN
- Phase
- PHASE2
EchoTip AcuCore Post-Market Clinical Study
- Status
- COMPLETED
- Phase
- N/A
Hepatocellular Carcinoma Liver Organoids
- Status
- RECRUITING
- Phase
- NA
Alectinib in Combination With Nivolumab in the Treatment of Recurrent or Refractory HCC Patients Guided With Serum RNase1 and Tumor Expression of PD-L1
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTT
- Status
- RECRUITING
- Phase
- PHASE2
A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.
- Status
- RECRUITING
- Phase
- NA
Early Detection of Liver Cancer by QUS
- Status
- RECRUITING
- Phase
- N/A
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
- Status
- RECRUITING
- Phase
- N/A
Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC)
- Status
- WITHDRAWN
- Phase
- PHASE1